BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Corthera 

1660 South Amphlett Boulevard
Suite 200
San Mateo  California  94402-2525  U.S.A.
Phone: 650-235-3555 Fax: 650-235-3579


SEARCH JOBS










 Company News
Novartis Corporation (NVS) (JOBS) To Pay Corthera Up To $620M For Heart Drug Rights 12/23/2009 6:58:51 AM
Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure 10/1/2009 10:44:51 AM
Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables 6/1/2009 8:35:43 AM
Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009 5/28/2009 11:20:18 AM
Corthera Release: Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure 3/30/2009 8:20:12 AM
Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at American College of Cardiology 3/23/2009 11:19:10 AM
Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure 11/10/2008 8:52:50 AM
Corthera Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at American Heart Association Scientific Sessions 2008 11/3/2008 7:48:20 AM
University of Cincinnati First in US to Study Corthera's Relaxin for Heart Failure 7/8/2008 2:47:09 PM
Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure 1/8/2008 8:00:52 AM
12